16a6
[DOCID: f:sr171is.txt]
107th CONGRESS
1st Session
S. RES. 171
Expressing the sense of the Senate concerning the provision of funding
for bioterrorism preparedness and response.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
October 11, 2001
Mr. Frist (for himself, Mr. Kennedy, Mr. Hatch, Mr. Breaux, Mr. Warner,
Ms. Mikulski, Mr. Murkowski, Mr. Dorgan, Mr. Bond, Mr. Cleland, Mr.
Burns, Mr. Reed, Mr. Inhofe, Mrs. Lincoln, Mr. Thompson, Mr. Santorum,
Mr. Allard, Ms. Collins, Mr. Enzi, Mr. Hutchinson, Mr. Hagel, Mr.
Roberts, Mr. Sessions, Mr. Chafee, Mrs. Clinton, and Mr. Domenici)
submitted the following resolution; which was referred to the Committee
on Health, Education, Labor, and Pensions
_______________________________________________________________________
RESOLUTION
Expressing the sense of the Senate concerning the provision of funding
for bioterrorism preparedness and response.
Whereas additional steps must be taken to better prepare the United States to
respond to potential bioterrorism attacks;
Whereas the threat of a bioterrorist attack is still remote, but is increasing
for a variety of reasons, including--
(1) public pronouncements by Osama bin Laden that it is his
religious duty to acquire weapons of mass destruction, including
chemical and biological weapons;
(2) the callous disregard for innocent human life as demonstrated by
the terrorists' attacks of September 11, 2001;
(3) the resources and motivation of known terrorists and their
sponsors and supporters to use biological warfare;
(4) recent scientific and technological advances in agent delivery
technology such as aerosolization that have made weaponization of
certain germs much easier; and
(5) the increasing access to the technologies and expertise
necessary to construct and deploy chemical and biological weapons of
mass destruction;
Whereas coordination of Federal, State, and local terrorism research,
preparedness, and response programs must be improved;
Whereas States, local areas, and public health officials must have enhanced
resources and expertise in order to respond to a potential bioterrorist
attack;
Whereas national, State, and local communication capacities must be enhanced to
combat the spread of chemical and biological illness;
Whereas greater resources must be provided to increase the capacity of hospitals
and local health care workers to respond to public health threats;
Whereas health care professionals must be better trained to recognize, diagnose,
and treat illnesses arising from biochemical attacks;
Whereas additional supplies may be essential to increase the readiness of the
United States to respond to a bio-attack;
Whereas improvements must be made in assuring the safety of the food supply;
Whereas new vaccines and treatments are needed to assure that we have an
adequate response to a biochemical attack;
Whereas government research, preparedness, and response programs need to utilize
private sector expertise and resources; and
Whereas now is the time to strengthen our public health system and ensure that
the United States is adequately prepared to respond to potential
bioterrorist attacks, natural infectious disease outbreaks, and other
challenges and potential threats to the public health: Now, therefore,
be it
Resolved, That it is the sense of the Senate that the United States
should make a substantial new investment this year toward the
following:
(1) Improving State and local preparedness capabilities by
upgrading State and local surveillance epidemiology, assisting
in the development of response plans, assuring adequate
staffing and training of health professionals to diagnose and
care for victims of bioterrorism, extending the electronics
communications networks and training personnel, and improving
public health laboratories.
(2) Improving hospital response capabilities by assisting
hospitals in developing plans for a bioterrorist attack and
improving the surge capacity of hospitals.
(3) Upgrading the bioterrorism capabilities of the Centers
for Disease Control and Prevention through improving rapid
identification and health early warning systems.
(4) Improving disaster response medical systems, such as
the National Disaster Medical System and the Metropolitan
Medical Response System and Epidemic Intelligence Service.
(5) Targeting research to assist with the development of
appropriate therapeutics and vaccines for likely bioterrorist
agents and assisting with expedited drug and device review
through the Food and Drug Administration.
(6) Improving the National Pharmaceutical Stockpile program
by increasing the amount of necessary therapies (including
smallpox vaccines and other post-exposure vaccines) and
ensuring the appropriate deployment of stockpiles.
(7) Targeting activities to increase food safety at the
Food and Drug Administration.
(8) Increasing international cooperation to secure
dangerous biological agents, increase surveillance, and retrain
biological warfare specialists.
<all>
0